Active, Not Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
NCT06298552
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +13 more
- Locations
-
- HonorHealth Neurology - Bob Bove Neuroscience Institute Scottsdale, Arizona, United States
- Loma Linda University Health Fresno, California, United States
- First Choice Neurology Boca Raton Boca Raton, Florida, United States
- SFM Clinical Research LLC Boca Raton, Florida, United States